Emergent BioSolutions on Thursday said the U.S. Food and Drug Administration (FDA) had approved expanded use of its ACAM2000 smallpox vaccine to include people at high risk for mpox infection.
Original Image Link
Source:www.reuters.com
Original Image Link
Source:www.reuters.com
Posted: 2024-08-29 03:22:00